Llwytho...
IVIG May Be An Effective Therapy for Refractory, Active Diffuse Cutaneous Scleroderma
OBJECTIVE: We sought to retrospectively review a single-center experience using intravenous immunoglobulin (IVIG) for the treatment of refractory, active diffuse cutaneous scleroderma. METHODS: The mean modified Rodnan skin score (mRSS) at baseline was compared to the mRSS at 6, 12, 18 and 24 months...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Rheumatol |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4314512/ https://ncbi.nlm.nih.gov/pubmed/25433527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.140833 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|